MedTrace Logo

Medical Management of Late Intrauterine Death.

NCT02488642 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-07-24

No results posted yet for this study

Summary

The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide dinitrate-oxytocin in combination in the management of late intrauterine foetal death.

Conditions

  • Cervical Pregnancy
  • Maternal Care for Late Fetal Death

Interventions

DRUG

Isosorbide Dinitrate

DRUG

Misoprostol

DRUG

Oxytocin

Oxytocin was infused in a balanced electrolyte solution beginning with an infusion rate of 2 milli-International Units per minute (mIU/min) and doubling the dose every 15 minutes.

Sponsors & Collaborators

  • National Council of Science and Technology, Mexico

    collaborator OTHER

  • National Institute of Perinatology

    lead OTHER_GOV

Principal Investigators

  • Gabriel Arteaga-Troncoso, PhD. · National Institute of Perinatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2013-09-30
Completion
2014-05-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02488642 on ClinicalTrials.gov